GlycoEra Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
35
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$130M
- Investors
-
14
GlycoEra General Information
Description
Operator of a biotech company intended for medical needs in inflammatory, autoimmune, and immune-oncology. The company offers a proprietary platform that develops therapeutics with customized and homogenous human glycans assembled onto glycoproteins in a site-specific manner, enabling healthcare companies to understand the role of glycans in human health and diseases.
Contact Information
Website
www.glycoera.comCorporate Office
- Einsiedlerstrasse 34
- 8820 Wädenswil
- Switzerland
Corporate Office
- Einsiedlerstrasse 34
- 8820 Wädenswil
- Switzerland
GlycoEra Timeline
GlycoEra Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series B) | 27-May-2025 | $130M | Completed | Clinical Trials - Phase 1 | ||
| 1. Early Stage VC (Series A) | 08-Jan-2024 | Completed | Pre-Clinical Trials |
GlycoEra Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
GlycoEra Comparisons
Industry
Financing
Details
GlycoEra Competitors (16)
One of GlycoEra’s 16 competitors is LimmaTech Biologics, a Formerly VC-backed company based in Schlieren, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| LimmaTech Biologics | Formerly VC-backed | Schlieren, Switzerland | ||||
| Cerecin | Venture Capital-Backed | Broomfield, CO | ||||
| Modag | Venture Capital-Backed | Wendelsheim, Germany | ||||
| Alzheon | Venture Capital-Backed | Framingham, MA | ||||
| Athos Therapeutics | Venture Capital-Backed | Los Angeles, CA |
GlycoEra Patents
GlycoEra Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025253185-A1 | Glycoengineered polypeptides targeting igg4 autoantibodies and uses thereof | Pending | 08-Apr-2024 | ||
| WO-2025215516-A1 | Glycoengineered polypeptides targeting igg4 autoantibodies and uses thereof | Pending | 08-Apr-2024 | ||
| WO-2024218743-A1 | Multi-functional molecules comprising glycans and uses thereof | Inactive | 21-Apr-2023 | ||
| AU-2024206743-A1 | Glycoengineered polypeptides targeting anti-neutrophil autoantibodies and uses thereof | Pending | 05-Jan-2023 | ||
| EP-4646221-A1 | Glycoengineered polypeptides targeting anti-neutrophil autoantibodies and uses thereof | Pending | 05-Jan-2023 | C12N15/62 |
GlycoEra Signals
GlycoEra Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Agent Capital | Venture Capital | Minority | ||
| Bristol-Myers Squibb Foundation | Limited Partner | Minority | ||
| Catalio Capital Management | Venture Capital | Minority | ||
| LifeArc Ventures | Venture Capital | Minority | ||
| MP Healthcare Venture Management | Corporate Venture Capital | Minority |
GlycoEra FAQs
-
When was GlycoEra founded?
GlycoEra was founded in 2020.
-
Where is GlycoEra headquartered?
GlycoEra is headquartered in Wädenswil, Switzerland.
-
What is the size of GlycoEra?
GlycoEra has 35 total employees.
-
What industry is GlycoEra in?
GlycoEra’s primary industry is Biotechnology.
-
Is GlycoEra a private or public company?
GlycoEra is a Private company.
-
What is GlycoEra’s current revenue?
The current revenue for GlycoEra is .
-
How much funding has GlycoEra raised over time?
GlycoEra has raised $194M.
-
Who are GlycoEra’s investors?
Agent Capital, Bristol-Myers Squibb Foundation, Catalio Capital Management, LifeArc Ventures, and MP Healthcare Venture Management are 5 of 14 investors who have invested in GlycoEra.
-
Who are GlycoEra’s competitors?
LimmaTech Biologics, Cerecin, Modag, Alzheon, and Athos Therapeutics are some of the 16 competitors of GlycoEra.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process